The current valuation score of Vanda Pharmaceuticals Inc is 7.70, ranking 153 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.26, which is -8479.94% below the recent high of 105.42 and -5972.31% above the recent low of -76.39.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.